The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
January 30th 2025
The drug is a selective NaV1.8 pain signal inhibitor and is the first new class of medication to treat acute pain in over 20 years.
The NCPA recently wrote to the U.S. House of Representatives and encouraged them to pass a bill that would make great strides in reducing the number of Americans misusing prescription drugs. Suncoast Rehab backs the NCPA in their efforts, and says that communities must take it one step further in fighting this epidemic.
Read More